📣 Try out the NEW Gateway to Research and let us know what you think.

We're looking for users to test the new service during August and September and share their feedback. Express your interest by completing this short form.

Predicting beneficial effects of atomoxetine and citalopram on response inhibition in Parkinson's disease with clinical and neuroimaging measures. (2016)

First Author: Ye Z
Attributed to:  Innovative Technologies for Stratified and Experimental Medicine funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1002/hbm.23087

PubMed Identifier: 26757216

Publication URI: http://europepmc.org/abstract/MED/26757216

Type: Journal Article/Review

Volume: 37

Parent Publication: Human brain mapping

Issue: 3

ISSN: 1065-9471